MX2016011842A - Composiciones tópicas de corticosteroides. - Google Patents

Composiciones tópicas de corticosteroides.

Info

Publication number
MX2016011842A
MX2016011842A MX2016011842A MX2016011842A MX2016011842A MX 2016011842 A MX2016011842 A MX 2016011842A MX 2016011842 A MX2016011842 A MX 2016011842A MX 2016011842 A MX2016011842 A MX 2016011842A MX 2016011842 A MX2016011842 A MX 2016011842A
Authority
MX
Mexico
Prior art keywords
compositions
topical corticosteroid
corticosteroid compositions
disorders
topical
Prior art date
Application number
MX2016011842A
Other languages
English (en)
Inventor
Kandavalli Sateesh
Sahukar Priyadarshani
Okumu Franklin
Original Assignee
Promius Pharma Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Promius Pharma Llc filed Critical Promius Pharma Llc
Publication of MX2016011842A publication Critical patent/MX2016011842A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Abstract

Composiciones para la administración tópica de un agente activo que comprenden un corticosteroide y un alcohol graso como aumentador de penetración en la piel, en la forma de rocíos tópicos. Procesos para preparar tales composiciones y métodos para usarlas en el manejo de enfermedades o trastornos de la piel tales como psoriasis, dermatosis, y otras enfermedades o trastornos de la piel asociados.
MX2016011842A 2014-03-11 2015-03-11 Composiciones tópicas de corticosteroides. MX2016011842A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461951165P 2014-03-11 2014-03-11
PCT/US2015/020031 WO2015138650A1 (en) 2014-03-11 2015-03-11 Topical corticosteroid compositions

Publications (1)

Publication Number Publication Date
MX2016011842A true MX2016011842A (es) 2017-02-02

Family

ID=52727460

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2016011842A MX2016011842A (es) 2014-03-11 2015-03-11 Composiciones tópicas de corticosteroides.
MX2016011841A MX2016011841A (es) 2014-03-11 2015-09-09 Composiciones topicas de corticosteroides.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2016011841A MX2016011841A (es) 2014-03-11 2015-09-09 Composiciones topicas de corticosteroides.

Country Status (13)

Country Link
US (4) US20150258119A1 (es)
EP (2) EP3116473B1 (es)
JP (2) JP6487949B2 (es)
KR (2) KR101930244B1 (es)
CN (1) CN106659682B (es)
AU (2) AU2015229403B2 (es)
BR (1) BR112016021023A2 (es)
CA (2) CA2945943C (es)
EA (2) EA201691808A8 (es)
ES (1) ES2857602T3 (es)
MX (2) MX2016011842A (es)
WO (2) WO2015138650A1 (es)
ZA (1) ZA201606704B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9364485B2 (en) 2009-08-31 2016-06-14 Dr. Reddy's Laboratories Ltd. Topical formulations comprising a steroid
US20160184431A1 (en) 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid
WO2017091168A1 (en) * 2015-11-28 2017-06-01 Pharmacti̇ve İlaç San. Ve Ti̇c. A.Ş. A topical spray comprising isoconazole nitrate and difluocortolone valerate
CA3011015C (en) * 2016-01-12 2024-04-16 Nortic Holdings Inc. Betamethasone oral spray formulation and method of use to treat ataxia
GB201604316D0 (en) 2016-03-14 2016-04-27 Avexxin As Combination therapy
WO2018020385A1 (en) * 2016-07-27 2018-02-01 Sun Pharmaceutical Industries Limited Touch-free topical spray of halobetasol
KR20190055153A (ko) 2016-09-21 2019-05-22 아벡신 에이에스 약학 조성물
US10543177B2 (en) 2017-04-11 2020-01-28 Kevin Mrohs Composition and method for treating skin conditions
US11620886B2 (en) 2018-02-19 2023-04-04 Invue Security Products Inc. Merchandise security system with inductive charging
CN113453670A (zh) * 2018-09-28 2021-09-28 乔·斯图丁 类固醇和大分子的透孔递送
JP7412292B2 (ja) * 2019-07-10 2024-01-12 積水化学工業株式会社 製剤
WO2021080527A1 (en) * 2019-10-24 2021-04-29 Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A.Ş. Topical pharmaceutical compositions containing difluocortolone and isoconazole
JP2023513694A (ja) * 2020-02-11 2023-04-03 タロー・ファーマシューティカル・インダストリーズ・リミテッド デスオキシメタゾンおよびタザロテンを含む組成物
US11382863B2 (en) * 2020-03-04 2022-07-12 Somerset Therapeutics Llc Injectable suspension comprising an insoluble corticosteroid and a soluble corticosteroid
CN113092601B (zh) * 2021-03-02 2022-12-20 苏州市药品检验检测研究中心 一种化妆品中倍他米松17-丙酸酯及倍他米松21-丙酸酯的检测方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3892856A (en) 1974-04-10 1975-07-01 Squibb & Sons Inc Topical steroid formulation
US3934013A (en) 1975-02-21 1976-01-20 Syntex (U.S.A.) Inc. Pharmaceutical composition
US4343798A (en) 1981-06-23 1982-08-10 The Procter & Gamble Company Topical antimicrobial anti-inflammatory compositions
US4552872A (en) * 1983-06-21 1985-11-12 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing corticosteroids
AU6974191A (en) * 1989-12-20 1991-07-18 Schering Corporation Stable cream and lotion bases for lipophilic drug compositions
IT1247529B (it) 1991-04-24 1994-12-17 Poli Ind Chimica Spa Composizioni farmaceutiche in forma di schiuma per somministrazione intravaginale, cutanea e orale
WO1996010389A1 (de) 1994-09-30 1996-04-11 Mika Pharma Gesellschaft Für Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh Pharmazeutische zusammensetzung
GB9504265D0 (en) 1995-03-03 1995-04-19 Medeva Plc Corticosteroid-containing pharmaceutical composition
IL152486A0 (en) * 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US20080206161A1 (en) * 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
US7820145B2 (en) * 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
CL2004001884A1 (es) * 2003-08-04 2005-06-03 Pfizer Prod Inc Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
CN101267804A (zh) * 2003-12-16 2008-09-17 弗米克斯有限公司 含油的药物和化妆品泡沫
CA2756674C (en) * 2004-08-31 2012-04-03 Stiefel Research Australia Pty Ltd Microemulsion & sub-micron emulsion process & compositions
TWI397427B (zh) * 2004-08-31 2013-06-01 Stiefel Res Australia Pty Ltd 微乳化液、次微米乳化液的方法及組成物
US20060246098A1 (en) * 2005-03-16 2006-11-02 Srinivasa Rao Stable aqueous-based emulsion formulation comprising urea and salicylic acid and method of using same
BRPI0608334A2 (pt) 2005-04-25 2009-12-01 Dow Pharmaceutical Sciences uso de uma formulação de clobetasol em lìquido pulverizado para o tratamento de psorìase
GB2443162B (en) 2006-10-28 2011-02-09 Nupharm Lab Ltd Betamethasone spray
US9364485B2 (en) * 2009-08-31 2016-06-14 Dr. Reddy's Laboratories Ltd. Topical formulations comprising a steroid
CA2776474C (en) * 2009-10-02 2021-01-12 Foamix Ltd. Topical tetracycline compositions
NL2004437C2 (en) * 2010-03-19 2011-09-20 Forte Iq B V Spray-pumpable comprising composition suitable for topical skin application.
CA2802041A1 (en) * 2010-06-11 2011-12-15 Precision Dermatology, Inc. High oil-content emollient aerosol foam compositions
JP6269487B2 (ja) * 2012-08-10 2018-01-31 旭硝子株式会社 カーボネート化合物および芳香族ポリカーボネートの製造方法
AU2014233362A1 (en) * 2013-03-15 2015-10-01 Medicis Pharmaceutical Corporation Topical compositions of flunisolide and methods of treatment
US10111956B2 (en) * 2013-06-03 2018-10-30 Tolmar, Inc. Corticosteroid compositions

Also Published As

Publication number Publication date
CN106659682B (zh) 2020-12-29
KR20170023791A (ko) 2017-03-06
CA2946201A1 (en) 2016-09-15
BR112016021023A2 (pt) 2021-09-14
CN106659682A (zh) 2017-05-10
EA201691808A1 (ru) 2017-02-28
US20160030450A1 (en) 2016-02-04
AU2015385750B2 (en) 2019-01-31
JP2017508802A (ja) 2017-03-30
US20200230155A1 (en) 2020-07-23
EP3197432A4 (en) 2018-10-10
JP6535735B2 (ja) 2019-06-26
CA2945943A1 (en) 2015-09-17
US20150258119A1 (en) 2015-09-17
WO2015138650A1 (en) 2015-09-17
KR101930246B1 (ko) 2018-12-18
JP2017530974A (ja) 2017-10-19
AU2015229403B2 (en) 2019-05-02
ES2857602T3 (es) 2021-09-29
EA201691808A8 (ru) 2017-04-28
KR20160144377A (ko) 2016-12-16
US20180250312A1 (en) 2018-09-06
WO2016144381A1 (en) 2016-09-15
AU2015229403A1 (en) 2016-10-27
ZA201606704B (en) 2019-07-31
EP3116473B1 (en) 2020-12-30
CA2945943C (en) 2020-10-27
BR112016021023A8 (pt) 2018-01-30
EP3116473A1 (en) 2017-01-18
JP6487949B2 (ja) 2019-03-20
MX2016011841A (es) 2017-02-02
EP3197432A1 (en) 2017-08-02
KR101930244B1 (ko) 2018-12-18
AU2015385750A1 (en) 2016-10-27
CA2946201C (en) 2020-10-27
EA201692334A1 (ru) 2018-02-28

Similar Documents

Publication Publication Date Title
MX2016011841A (es) Composiciones topicas de corticosteroides.
PH12018500586A1 (en) Farnesoid x receptor agonists and uses thereof
CO2018001375A2 (es) Composiciones de retinoides tópicos
MX2020009780A (es) Compuestos de inhibidor de autotaxina.
WO2011026076A3 (en) Topical formulations comprising a steroid
PH12017501095A1 (en) Piperidine derivatives as hdac1/2 inhibitors
MX2016013280A (es) Composiciones topicas para el alivio del dolor, manufactura y uso.
IN2015DN03069A (es)
PH12016500863A1 (en) Tetracyclic autotaxin inhibitors
MX2017005861A (es) Metodos para el control transcripcional objetivo en regiones del super mejorador.
WO2014121137A3 (en) Compositions and methods for the treatment of neurodegenerative and other diseases
MY193312A (en) Topical formulation for promoting wound healing
AU2016206832A8 (en) Non-invasive systems and methods for treatment of a host carrying a virus with photoactivatable drugs
EP3138834A4 (en) Cyclohexene derivative, preparation method therefor, and pharmaceutical composition for preventing or treating metabolic diseases, containing same as active ingredient
MX2016008150A (es) Formulaciones de berberina y usos de las mismas.
MX2016015211A (es) Formulaciones topicas y usos de las mismas.
PH12014501573A1 (en) Topical pharmaceutical compositions comprising bexarotene and a corticosteroids
ITUB20152862A1 (it) Veicolo per terapia fotodinamica topica con acido delta-aminolevulinico in ambito dermatologico e metodo di preparazione del veicolo stesso.
MX2016003950A (es) Composicion para rocio topica de halobetasol sin propelente.
SG10201810362SA (en) Anti-allergic agent, agent for improving allergic diarrhea and pharmaceutical composition
PH12020500472A1 (en) Autotaxin inhibitor compounds
PH12017500173A1 (en) Post-harvest disease control agent and post-harvest disease control method
MX2018002449A (es) Formulaciones de liberacion retardada, metodos de fabricacion y uso de las mismas.
UA92452U (ru) Способ заживления местных лучевых повреждений кожи
UA92219U (ru) Лекарственное средство с метронидазолом для лечения дерматологических заболеваний